Autolus Therapeutics (Autolus Therapeutics) Accounts Payable & Accrued Expense : $24.39 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Accounts Payable & Accrued Expense?

Autolus Therapeutics's quarterly accounts payable & accrued expense declined from Jun. 2023 ($25.21 Mil) to Sep. 2023 ($21.40 Mil) but then increased from Sep. 2023 ($21.40 Mil) to Dec. 2023 ($24.39 Mil).

Autolus Therapeutics's annual accounts payable & accrued expense increased from Dec. 2021 ($15.19 Mil) to Dec. 2022 ($30.75 Mil) but then declined from Dec. 2022 ($30.75 Mil) to Dec. 2023 ($24.39 Mil).

Autolus Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Autolus Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Accounts Payable & Accrued Expense Chart

Autolus Therapeutics Annual Data

Trend

Sep16

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

15.19

20.82

15.19

30.75

24.39

Autolus Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															30.75	26.67	25.21	21.40	24.39

Autolus Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Autolus Therapeutics (Autolus Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

6A3A:Germany

Address

191 Wood Lane, The MediaWorks, London, GBR, W12 7FP

Website

https://www.autolus.com

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.